Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Transgender and gender-diverse teens need specialized skin and mental health care.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Continuous learning and personalized treatments are crucial in dermatology due to rapid technological advancements.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hair restoration surgery for women is improving with better techniques and understanding.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Hair significantly shapes body identity and social interactions, influencing how we perceive and relate to our bodies.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

The procedure effectively created natural-looking hairlines and improved facial balance in female patients.